VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
Both of Moderna's COVID-19 vaccines for the 2025-2026 season have demonstrated strong immune responses against today's top circulating COVID-19 strains
MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
The study showed that sClever-1 is released by macrophages and blood vessel cells and binds to activated T cells
Sun Pharma has been involved in a patent infringement case with Incyte Corporation over LEQSELVI
Partnership to Combine AbbVie's Oncology Expertise with EvolveImmune's Proprietary EVOLVE T-Cell Engager Platform to Develop Novel Multispecific Therapeutic Antibodies for Cancer
New data for Tezspire and Breztri demonstrate AstraZeneca’s innovation and commitment to transform care in COPD
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
Subscribe To Our Newsletter & Stay Updated
